A shared excerpt points to TRIUMPH-2 results on how well retatrutide works and how safe it is. The snippet gives no numbers, so the full piece has the data.
Recap by typeshit. Post by Facebook on Facebook.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
The frozen food brand is targeting people on weight loss drugs with a new veggie range, another sign of food companies chasing the GLP-1 crowd.
16:36
Fitness coach Mike Thurston gives his personal opinion on peptides after using them for several months. His views are his own, not medical advice.
Loading…